Hemodynamic Measurements in Women With Serious Preeclampsia

The recruitment status of this study is unknown because the information has not been verified recently.
Verified September 2009 by Oslo University Hospital.
Recruitment status was  Recruiting
Information provided by:
Oslo University Hospital
ClinicalTrials.gov Identifier:
First received: September 15, 2005
Last updated: September 15, 2009
Last verified: September 2009
This trial is examining hemodynamic measurements in women with serious preeclampsia.

Condition Phase
Phase 4

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Hemodynamic Measurements in Women With Serious Preeclampsia

Resource links provided by NLM:

Further study details as provided by Oslo University Hospital:

Primary Outcome Measures:
  • Hemodynamic variations in preeclamptic women [ Time Frame: days ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Urine output [ Time Frame: days ] [ Designated as safety issue: No ]
  • thrombocyte count [ Time Frame: days ] [ Designated as safety issue: No ]

Estimated Enrollment: 80
Study Start Date: July 2005
Estimated Study Completion Date: December 2006

Ages Eligible for Study:   18 Years to 50 Years
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Pregnant women with moderate-to-severe pre-eclampsia

Inclusion Criteria:

  • Women with serious preeclampsia
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00199810

Contact: Eldrid Langesæter, MD + 47 23073000 eldrid.langesaeter@rikshospitalet.no

Rikshospitalet-Radiumhospitalet HF Recruiting
Oslo, Norway, 0027
Sponsors and Collaborators
Oslo University Hospital
Principal Investigator: Eldrid Langesæter Langesæter Oslo University Hospital
  More Information

Responsible Party: Rikshospitalet Radiumhospitalet HF
ClinicalTrials.gov Identifier: NCT00199810     History of Changes
Other Study ID Numbers: Elangepreeklampsi2005-  S-05173 
Study First Received: September 15, 2005
Last Updated: September 15, 2009
Health Authority: Norway: Norwegian Medicines Agency

Keywords provided by Oslo University Hospital:
Cardiac output
Preeclamptic women
systemic vascular resistance
blood pressure

Additional relevant MeSH terms:
Hypertension, Pregnancy-Induced
Pregnancy Complications

ClinicalTrials.gov processed this record on May 26, 2016